Changes in clearance of sodium valproate with changes in dose

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Clinical Pharmacology
• Neuropharmacology

Background:

• Sodium valproate is a widely used antiepileptic and mood-stabilizing drug.
• Understanding the relationship between drug concentration, unbound fraction, and clearance is crucial for optimizing therapeutic efficacy and minimizing toxicity.
• Previous studies have suggested different clearance mechanisms for sodium valproate, necessitating further investigation.

Purpose of the Study:

• To investigate the relationship between total sodium valproate concentrations and its clearance in patients.
• To evaluate how changes in sodium valproate dose affect drug clearance and unbound fraction.
• To elucidate the clearance mechanism of sodium valproate, specifically whether it is restrictively or nonrestrictively cleared.

Main Methods:

• Pharmacokinetic analysis was performed in four patients receiving sodium valproate.
• Drug clearance was evaluated at two different dosage levels for each patient.
• The unbound fraction of sodium valproate was measured over dosing intervals to assess its relationship with dose and clearance.

Main Results:

• In all patients, the average unbound fraction of sodium valproate increased with higher doses.
• Despite the increased unbound fraction, total drug clearance did not increase with higher doses.
• Clearance of the unbound fraction of sodium valproate decreased in each patient as the dose increased.

Conclusions:

• The findings suggest a dose-related decline in intrinsic clearance, indicating that sodium valproate may be restrictively cleared.
• Alternatively, these results challenge previous reports and suggest that sodium valproate might be cleared nonrestrictively.
• Further research is warranted to definitively determine the clearance mechanism of sodium valproate at varying doses.